Featured Research

from universities, journals, and other organizations

Psoriasis-like Inflammation: Crucial Role For The Protein CCR6

Date:
July 6, 2009
Source:
Journal of Clinical Investigation
Summary:
Psoriasis, a chronic skin disorder caused by the immune system, affects 1%-2% of white individuals. Although there are a number of treatments, the chronic recurrent nature of the disorder means more efficient therapies are being sought. Work in a mouse model of psoriasis-like inflammation has provided new insight into the immune mechanisms that likely underlie psoriasis and identified a potential new drug target.

Psoriasis, a chronic skin disorder caused by the immune system, affects 1%-2% of white individuals. Although there are a number of treatments, the chronic recurrent nature of the disorder means more efficient therapies are being sought. Work in a mouse model of psoriasis-like inflammation, by Joshua Farber and colleagues, at the National Institute of Allergy and Infectious Diseases, Bethesda, has provided new insight into the immune mechanisms that likely underlie psoriasis and identified a potential new drug target.

Related Articles


In the study, when the soluble immune molecule IL-23 was injected into the ears of normal mice the ears developed psoriasis-like inflammation. By contrast, no inflammation developed when IL-23 was injected into the ears of mice lacking the protein CCR6. As immune cells known as Th17 cells express CCR6, initial analysis focused on these cells. Consistent with a role for these cells in the IL-23–induced psoriasis-like inflammation, injection of the immune molecule IL-22 (which is produced by Th17 cells) into the ears of normal and CCR6-deficient mice induced equivalent inflammation.

However, further analysis indicated that the IL-22 did not come from Th17 cells, rather it came from a non–T cell source. The authors therefore conclude that CCR6 is essential for IL-23–induced, IL-22–mediated psoriasis-like inflammation, which initially develops in a T cell–independent manner, and suggest that CCR6 might be a therapeutic target for the treatment of psoriasis.


Story Source:

The above story is based on materials provided by Journal of Clinical Investigation. Note: Materials may be edited for content and length.


Journal Reference:

  1. CCR6 is required for IL-23-induced psoriasis-like inflammation in mice. Journal of Clinical Investigation, July 7, 2009

Cite This Page:

Journal of Clinical Investigation. "Psoriasis-like Inflammation: Crucial Role For The Protein CCR6." ScienceDaily. ScienceDaily, 6 July 2009. <www.sciencedaily.com/releases/2009/07/090706171503.htm>.
Journal of Clinical Investigation. (2009, July 6). Psoriasis-like Inflammation: Crucial Role For The Protein CCR6. ScienceDaily. Retrieved October 24, 2014 from www.sciencedaily.com/releases/2009/07/090706171503.htm
Journal of Clinical Investigation. "Psoriasis-like Inflammation: Crucial Role For The Protein CCR6." ScienceDaily. www.sciencedaily.com/releases/2009/07/090706171503.htm (accessed October 24, 2014).

Share This



More Health & Medicine News

Friday, October 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Doctor in NYC Quarantined With Ebola

Doctor in NYC Quarantined With Ebola

AP (Oct. 24, 2014) An emergency room doctor who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus. He's quarantined in a hospital. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins